Science & Technology
Science and TechnologyScience and Technology 
Wed, June 22, 2011
Tue, June 21, 2011
Probe Manufacturing Secures $225,000 Medical Device Manufacturing Contract and Exceeds $2.6 Million in Open Orders
IRVINE, Calif.--([ BUSINESS WIRE ])--Probe Manufacturing, Inc., [ (Pink Sheets:PMFI) ][ http://www.probeglobal.com/ ], a global electronics design and manufacturing services company is pleased to announce that it has secured a $225,000 blanket purchase order from an existing medical device manufacturing client with 50% of the order due in 3rd and 4th quarters of 2011. Probe is now on target to achieve its 2011 revenue and earnings forecast.
"Probea™s ability to drive its growth organically from its existing customer base is clearly demonstrated by this latest order, which also exhibits the overall confidence and satisfaction that Probe's current client base has in our company"
New orders have increased from $1.3 million to $3.0 million, or 130%, year-to-date as compared to the same period last year, bringing our total open orders to $2.6 million. aProbea™s ability to drive its growth organically from its existing customer base is clearly demonstrated by this latest order, which also exhibits the overall confidence and satisfaction that Probe's current client base has in our company,a stated Kam Mahdi, CEO and Chairman.
About Probe Manufacturing, Inc.
Probe Manufacturing is a global electronics design & manufacturing services company providing innovators with business services through our factory in California as well as factories worldwide. Headquartered in Irvine, California, Probe has been serving industrial, instrumentation, medical, aerospace, defense, and automotive industries since 1994. Probea™s common stock is traded on the bulletin board under the symbol PMFI.PK. Further information is available on Probea™s website: [ www.probeglobal.com ].
This release contains certain forward-looking statements (under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) with respect to whether Probe can maintain its revenue growth experienced year-to-date and whether such new business will be profitable for the company.Because such statements include risks, uncertainties and contingencies, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, but are not limited to, the following: uncertainties relating to changes in general economic and market conditions; uncertainties regarding changes in the EMS industry; the uncertainties relating to the implementation of our global business strategy; and other risk factors as outlined in the companya™s periodic reports, as filed with the U.S. Securities and Exchange Commission. Forward-looking statements in this document speak only as of the date on which such statements were made, and we undertake no obligation to update any such statements that may become untrue because of subsequent events. We claim the safe harbor protection for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.